Table 1 Backgrounds of the patients with systemic lupus erythematosus (SLE)
From: Role of lupus retinopathy in systemic lupus erythematosus
Lupus retinopathy | ||
|---|---|---|
Absent | Present | |
Number of SLE patients | 80 | 11 |
Number of SLE admitted cases | 6/91 (6.6 %) | 3/11 (27.3 %) |
Age at onset of SLE (years) | 31.9 | 30.4 |
Oral Steroid dose at ophthalmological examination (range) | 5–50 mg | 10–40 mg |
History of intravenous steroid | 3/91 (3.3 %) | 1/11 (9.1 %) |
History of immunosuppressant treatment | 8/91 (8.8 %) | 1/11 (9.1 %) |